Advanced glycation end-products: a review

R Singh, A Barden, T Mori, L Beilin - Diabetologia, 2001 - Springer
Advanced glycation end-products are a complex and heterogeneous group of compounds
that have been implicated in diabetes related complications. At present it is not known if they …

Advanced glycation End-products (AGEs): an emerging concern for processed food industries

C Sharma, A Kaur, SS Thind, B Singh… - Journal of food science and …, 2015 - Springer
The global food industry is expected to increase more than US $7 trillion by 2014. This rise
in processed food sector shows that more and more people are diverging towards modern …

Advanced glycation end products, oxidative stress and diabetic nephropathy

S Yamagishi, T Matsui - Oxidative medicine and cellular …, 2010 - Wiley Online Library
About 246 million people worldwide had diabetes in 2007. The global figure of people with
diabetes is projected to increase to 370 million in 2030. As the prevalence of diabetes has …

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

S Yamagishi, T Imaizumi - Current pharmaceutical design, 2005 - ingentaconnect.com
Diabetic vascular complication is a leading cause of end-stage renal failure, acquired
blindness, a variety of neuropathies and accelerated atherosclerosis, which could account …

[PDF][PDF] Diabetes and advanced glycoxidation end products

AG Huebschmann, JG Regensteiner, H Vlassara… - Diabetes …, 2006 - academia.edu
The morbidity caused by diabetes has traditionally been classified into macro-and
microvascular complications. Although macrovascular complications have received greater …

[HTML][HTML] The role of advanced glycation end products and its soluble receptor in kidney diseases

M Steenbeke, R Speeckaert, S Desmedt… - International Journal of …, 2022 - mdpi.com
Patients with chronic kidney disease (CKD) are more prone to oxidative stress and chronic
inflammation, which may lead to an increase in the synthesis of advanced glycation end …

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II

S Doublier, G Salvidio, E Lupia, V Ruotsalainen… - Diabetes, 2003 - Am Diabetes Assoc
We studied the distribution of nephrin in renal biopsies from 17 patients with diabetes and
nephrotic syndrome (7 type 1 and 10 type 2 diabetes), 6 patients with diabetes and …

[HTML][HTML] Glycation induces formation of amyloid cross-β structure in albumin

B Bouma, LMJ Kroon-Batenburg, YP Wu… - Journal of biological …, 2003 - ASBMB
Amyloid fibrils are components of proteinaceous plaques that are associated with
conformational diseases such as Alzheimer's disease, transmissible spongiform …

[HTML][HTML] Elevation of circulating endothelial microparticles in patients with chronic renal failure

V Faure, L Dou, F Sabatier, C Cerini, J Sampol… - Journal of Thrombosis …, 2006 - Elsevier
Background: Chronic renal failure patients are at high risk of cardiovascular events and
display endothelial dysfunction, a critical element in the pathogenesis of atherosclerosis …

Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients

J Uribarri, M Peppa, W Cai, T Goldberg… - Journal of the …, 2003 - journals.lww.com
Advanced glycation endproduct (AGE) levels are elevated in renal failure patients and may
contribute to the excessive cardiovascular disease in this population. Diet-derived AGE are …